Advertisement
Singapore markets close in 1 hour 42 minutes
  • Straits Times Index

    3,175.66
    -12.00 (-0.38%)
     
  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     
  • Hang Seng

    16,220.80
    -165.07 (-1.01%)
     
  • FTSE 100

    7,839.59
    -37.46 (-0.48%)
     
  • Bitcoin USD

    64,410.57
    +3,085.64 (+5.03%)
     
  • CMC Crypto 200

    1,334.37
    +21.75 (+1.69%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • Dow

    37,775.38
    +22.07 (+0.06%)
     
  • Nasdaq

    15,601.50
    -81.87 (-0.52%)
     
  • Gold

    2,405.90
    +7.90 (+0.33%)
     
  • Crude Oil

    83.70
    +0.97 (+1.17%)
     
  • 10-Yr Bond

    4.6470
    0.0000 (0.00%)
     
  • FTSE Bursa Malaysia

    1,548.70
    +3.94 (+0.25%)
     
  • Jakarta Composite Index

    7,095.77
    -71.04 (-0.99%)
     
  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

A Financial Overview of Sangamo Therapeutics in December 2018

A Financial Overview of Sangamo Therapeutics in December 2018

Who Is Eyeing Sangamo Therapeutics Now?(Continued from Prior Part)Revenue trends In the first nine months of 2018, Sangamo Therapeutics’ (SGMO) net revenues grew ~145% to reach $57.6 million from $23.